The Department of Health in England has proposed an additional 10 percentage point reduction on the maximum price pharmaceutical companies can charge the NHS for branded medicines, bringing the reduction total to 25%. The move is intended to align the scheme with the voluntary Pharmaceutical Price Regulation Scheme (PPRS). Read more here. (Source: Ingrid Torjesen, Pharmaceutical Journal, 10/17/14).
You are here: / / Could England See A 25% Cut In Pharmaceutical Pricing?